Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nose Cancer”

607 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 607 results

Early research (Phase 1)Active Not RecruitingNCT00336063
What this trial is testing

Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-Cell LymphomaRecurrent Nasopharyngeal Keratinizing Squamous Cell CarcinomaRecurrent Nasopharyngeal Undifferentiated Carcinoma+2 more
National Cancer Institute (NCI) 18
Not applicableUnknownNCT04462185
What this trial is testing

A Prospective Cohort Study of Chinese Patients With Pulmonary Nodules: Prediction of Lung Cancer Using Noninvasive Biomarkers

Who this might be right for
Pulmonary Nodules
AnchorDx Medical Co., Ltd. 3,000
Testing effectiveness (Phase 2)Study completedNCT00418535
What this trial is testing

Clinical Study of Chemoradiation Followed by VIPD in Nasal Natural Killer (NK)/T-cell Lymphoma

Who this might be right for
Lymphoma, T-Cell
Samsung Medical Center
Testing effectiveness (Phase 2)UnknownNCT04676789
What this trial is testing

Anti-PD-1 Antibody and Pegaspargase Combined With Radiotherapy in Early-Stage ENKTL

Who this might be right for
Extranodal NK/T-cell Lymphoma, Nasal Type
Sun Yat-sen University 30
Not applicableUnknownNCT05510388
What this trial is testing

HFNO Reduces Hypoxia During Sedated Gastroscopy or Colonoscopy in High Risk Patients

Who this might be right for
Gastric CancerIntestinal CancerIntestine Adenoma+1 more
RenJi Hospital 450
Not applicableStudy completedNCT02844842
What this trial is testing

Evaluation of Tolerability and Safety of "Allergovac Poliplus" in Polysensitized Patients With Rhinitis or Allergic Rhinoconjunctivitis With or Without Asthma: A Study in Daily Clinical Practice

Who this might be right for
Allergic RhinitisRhinoconjunctivitisAsthma
Roxall Medicina España S.A 152
Large-scale testing (Phase 3)Study completedNCT01156142
What this trial is testing

Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy

Who this might be right for
Head and Neck CancerMucositisOral Complications of Radiation Therapy+1 more
Alliance for Clinical Trials in Oncology 155
Post-approval studies (Phase 4)Ended earlyNCT01812759
What this trial is testing

Fentanyl for Breakthrough Pain in the Emergency Department

Who this might be right for
Pain
M.D. Anderson Cancer Center 3
Early research (Phase 1)Study completedNCT00589381
What this trial is testing

Fenretinide Lym-X-Sorb™ in Treating Patients With Recurrent or Resistant Solid Tumors or Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
National Institutes of Health Clinical Center (CC) 30
Not applicableStudy completedNCT00898872
What this trial is testing

SWOG-9245 Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial

Who this might be right for
Lymphoma
SWOG Cancer Research Network 32
Testing effectiveness (Phase 2)Study completedNCT00055913
What this trial is testing

Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Recurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the LarynxRecurrent Squamous Cell Carcinoma of the Lip and Oral Cavity+10 more
National Cancer Institute (NCI) 58
Testing effectiveness (Phase 2)Study completedNCT01177371
What this trial is testing

High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+70 more
Case Comprehensive Cancer Center 13
Testing effectiveness (Phase 2)Looking for participantsNCT06376721
What this trial is testing

Linperlisib Combined With Camrelizumab and Pegaspargase in Advanced or Relapsed/Refractory NK/T-cell Lymphoma

Who this might be right for
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeT-lymphoblastic Lymphoma
Beijing Tongren Hospital 43
Not applicableUnknownNCT04559087
What this trial is testing

Comparison of NOSES and Conventional Laparoscopic Surgery in Colorectal Cancer

Who this might be right for
Colorectal Cancer
Zunyi Medical College 200
Testing effectiveness (Phase 2)Study completedNCT00416351
What this trial is testing

Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Who this might be right for
LeukemiaLymphomaSmall Intestine Cancer
Memorial Sloan Kettering Cancer Center 29
Testing effectiveness (Phase 2)UnknownNCT02560441
What this trial is testing

Trial of IPGDP Regimen Chemotherapy in Patients With Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type

Who this might be right for
Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
Chinese Academy of Medical Sciences
Early research (Phase 1)Ended earlyNCT01643603
What this trial is testing

Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies

Who this might be right for
Non-Hodgkin's LymphomaHodgkin's LymphomaMyeloid Leukemia+3 more
Barbara Ann Karmanos Cancer Institute 5
Early research (Phase 1)WithdrawnNCT00521261
What this trial is testing

Donor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00040846
What this trial is testing

Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+97 more
Fred Hutchinson Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT00292695
What this trial is testing

A Phase II Study of Nasal NK/T-cell Lymphoma

Who this might be right for
Lymphoma
National Health Research Institutes, Taiwan 33
Load More Results